|
16 Jul 2025 |
Navin Fluorine
|
Consensus Share Price Target
|
4967.20 |
4727.25 |
- |
-4.83 |
buy
|
|
|
|
|
17 Jun 2021
|
Navin Fluorine
|
Axis Direct
|
4967.20
|
3930.00
|
3376.25
(47.12%)
|
Target met |
Buy
|
|
|
We initiate coverage with a BUY recommendation and value the stock at 38x of its FY24x EPS with a target price of Rs.3,930/share, implying an upside of 17%.
|
|
11 May 2021
|
Navin Fluorine
|
Edelweiss
|
4967.20
|
3525.00
|
3162.90
(57.05%)
|
Target met |
Buy
|
|
|
Progress in complex molecules to augur well
|
|
10 May 2021
|
Navin Fluorine
|
ICICI Securities Limited
|
4967.20
|
3460.00
|
3213.35
(54.58%)
|
Target met |
Hold
|
|
|
The company has been undertaking a capex of | 195 crore for the speciality chemical segment along with HPP plant with a capex of | 436 crore already in construction. The asset turn is expected to be around 1.3-1.5x. This would entail strong growth for high value segment. In turn, this translates into higher gross margins and thereby operational performance. We also expect that since the company is already working on more than 20 molecules for speciality chemical segment, this should support double digit revenue growth for the segment. Further, higher utilisation for CRAMS should...
|
|
28 Jan 2021
|
Navin Fluorine
|
ICICI Securities Limited
|
4967.20
|
2820.00
|
2344.25
(111.89%)
|
Target met |
Hold
|
|
|
Navin Fluorine reported topline growth of 19% YoY to | 309 crore against our estimate of | 305 crore. The growth was largely led by the CRAMS, speciality chemical segments, which were up 51% YoY, 26% YoY to | 71 crore, | 122 crore, respectively. Revenue from inorganic fluoride remained higher by 12% YoY to | 57 crore while the same from refrigerant was down 18% YoY to | 47 crore. Despite the value added segments, revenue remained higher compared to legacy business. Gross margins for the quarter fell 342 bps YoY to 53.9%, leading to lower than expected EBITDA...
|
|
17 Dec 2020
|
Navin Fluorine
|
ICICI Securities Limited
|
4967.20
|
3040.00
|
2555.90
(94.34%)
|
Target met |
Buy
|
|
|
Navin Fluorine has outlined capital expenditure for setting up a multipurpose plant (MPP) with an outlay of | 195 crore. The capex will be undertaken by its wholly owned subsidiary, Navin Fluorine Advanced Sciences Ltd at Dahej, Gujarat. The new capacity is expected to come on stream during H1FY23 and will create opportunities for new products in life science and crop science sectors in the specialty chemicals business. The company has already identified potential 12 new products of which five are going to be commercialised initially, which find application in crop protection. This new capacity would retain a mix of 50:50 among life science...
|
|
17 Dec 2020
|
Navin Fluorine
|
Edelweiss
|
4967.20
|
2817.00
|
2621.20
(89.50%)
|
Target met |
Buy
|
|
|
Navin Fluorine International Ltd (NFIL) has announced capex of INR195cr to set up a multi-purpose plant (MPP) for its Specialty Chemicals business at Dahej
|
|
02 Nov 2020
|
Navin Fluorine
|
Edelweiss
|
4967.20
|
2394.00
|
2178.60
(128.00%)
|
Target met |
Buy
|
|
|
Navin Fluorine International Ltd (NFIL) delivered a strong performance in Q2FY21.
|
|
30 Oct 2020
|
Navin Fluorine
|
Dolat Capital
|
4967.20
|
2463.00
|
2318.90
(114.21%)
|
Target met |
Accumulate
|
|
|
Navin Fluorine International Ltd (NFIL IN) reported a stellar 2QFY21 performance. Sales/EBITDA/PAT beat our estimates as Sales grew by 16.8% YoY to Rs 3.19bn (D.est: Rs 2.56bn)....
|
|
09 Oct 2020
|
Navin Fluorine
|
ICICI Securities Limited
|
4967.20
|
2550.00
|
1977.25
(151.22%)
|
Target met |
Buy
|
|
|
|
|
25 Jun 2020
|
Navin Fluorine
|
Edelweiss
|
4967.20
|
1837.00
|
1557.50
(218.92%)
|
Target met |
Buy
|
|
|
Navin Fluorine International Ltd (NFIL) is a pure-play fluorochemical company in India, with a significant focus on research and development.
|